dilluns, 14 d’abril del 2014

TAVI: Medtronic vows to appeal CoreValve ban in patent loss to Edwards Lifesciences




Medtech titan Medtronic plans to seek immediate appeal of a preliminary court injunction banning sales of its CoreValve transcatheter aortic valve implantation system.





TAVI: Medtronic has 7 days to appeal CoreValve ban in patent loss to Edwards Lifesciences



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1kYcOzO

Cap comentari:

Publica un comentari a l'entrada